Ambroxol Hydrochloride Dispersible Tablets is a drug with phlegm-suppressing effect, which is mainly used clinically for the treatment of acute and chronic pulmonary diseases with abnormal sputum secretion, or poor sputum excretion function, such as acute attacks of chronic bronchitis and bronchiectasis, and expectorant treatment of bronchial asthma. Ambroxol Hydrochloride Dispersible Tablets can significantly reduce the production of secretions in the respiratory tract, promote the decomposition of sputum, make the mucous sputum easily expelled, and reduce the retention of sputum. Ambroxol Hydrochloride Dispersible Tablets can promote cilia oscillation, which can significantly reduce the amount of coughing and coughing up sputum, reduce the inflammatory irritation of sputum to the respiratory tract, and promote the active substances on the surface of the upper mucous membrane of the respiratory tract to play a protective role to the respiratory tract.